MetLife
$94.35Change from previous close: +0.20%Absolute change: +$0.19
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- $59.96B
- Enterprise value
- $83.47B
- P/E (trailing 12 months)
- 18.0
- Forward P/E
- 8.64
- PEG
- 0.50
- Price/book
- 2.19
- Price/sales
- 0.76
- EV/EBITDA
- 13.8
- EV/revenue
- 1.05
Profitability and growth
- Gross margin
- 24.0%
- Operating margin
- 5.5%
- Net margin
- 4.6%
- ROE
- 13.1%
- ROA
- 0.5%
- Revenue growth (year over year)
- 10.5%
- Earnings growth (year over year)
- 5.8%
Financial health
- Total cash
- $27.32B
- Total debt
- $50.31B
- Debt/equity
- 1.80
- Current ratio
- 2.03
- Quick ratio
- 1.71
Dividends
- Annual dividend per share
- $2.37
- Dividend yield
- 2.5%
- Payout ratio
- 44.0%
- Ex-dividend date
- August 4, 2026
Analysts and estimates
- Average price target
- $105.88
- Median price target
- $108.00
- High price target
- $119.00
- Low price target
- $84.00
- Analysts with a price target
- 16
- Consensus
- Buy
- Forward EPS
- $10.92
- EPS estimate, current year
- $9.91
Shares and trading
- Beta
- 0.76
- Average volume
- 3.37M
- Shares outstanding
- 635.48M
- Float
- 531.23M
- Institutional ownership
- 78.3%
- Insider ownership
- 16.3%
- Short interest (% of float)
- 1.9%
- Short ratio (days)
- 4.30